PDK4 and breast carcinoma: Furthermore, miR-16-5p overexpression improved TAMR sensitivity in breast cancer cells [23] and cisplatin treatment sensitivity in osteosarcoma cells [24] and participated in anti-adriamycin chemoresistance in cervical cancer through PDK4-mediated metabolic reprogramming [25].